Eurofarma Laborat?rios S/A Pharmaceutical Import Profile — Brazil (DGFT 2022–2026)

Name: Eurofarma Laborat?rios S/A Pharmaceutical Import Records from India — 2 Products, $6.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Eurofarma Laborat?rios S/A — Pharmaceutical Importer Profile (2026) | 2 Products, $6.1M Trade | TransData Nexus

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Esomeprazole	Gastrointestinal	$3.0M	61	0.7%	12
2	Magnesium	Vitamins & Supplements	$3.0M	61	0.8%	12

Eurofarma Laborat?rios S/A imports 2 pharmaceutical products across 2 categories into Brazil totaling $6.1M.

Eurofarma Laborat?rios S/A — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Eurofarma Laboratórios S.A., established in 1972, is a Brazilian multinational pharmaceutical company headquartered in São Paulo. It is one of the largest medicine producers in Brazil and Latin America, offering a diverse portfolio that includes generic, oncologic, and veterinary medications. The company operates in 24 countries, covering 100% of the Latin American market, and employs over 13,000 individuals.

In Brazil, Eurofarma provides more than 4,000 stock-keeping units (SKUs), encompassing 42 medical specialties and over 140 therapeutic classes. This extensive range positions the company as a significant player in the Brazilian pharmaceutical sector.

2Distribution Network

Eurofarma's distribution network is extensive, with operations in 24 countries, including Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay, and Venezuela. The company has manufacturing facilities in several of these countries, enabling efficient logistics and supply chain management. While specific warehouse locations are not publicly disclosed, Eurofarma's widespread presence suggests a robust infrastructure capable of supporting its diverse product offerings across Latin America.

3Industry Role

Eurofarma Laboratórios S.A. plays a multifaceted role in Brazil's pharmaceutical supply chain. It functions as a primary wholesaler, distributing a wide array of pharmaceutical products to various healthcare providers. Additionally, the company engages in parallel importing, sourcing medications from international markets to meet local demand. Eurofarma also supplies hospitals directly, ensuring the availability of essential medicines in healthcare facilities. Its comprehensive approach positions the company as a pivotal entity in the Brazilian pharmaceutical landscape.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Eurofarma Laborat?rios S/A

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Eurofarma's sourcing strategy exhibits a high degree of concentration, with its top five imported products accounting for 100% of its pharmaceutical imports from India. This indicates a strategic focus on specific high-demand medications, potentially leveraging favorable pricing or exclusive distribution agreements. However, such concentration may pose risks related to supply chain disruptions or regulatory changes affecting these products. The stability of Eurofarma's relationship with Indian suppliers is crucial, as any fluctuations in the supply of these key products could significantly impact the company's operations.

2Supply Chain Resilience

Eurofarma's supply chain resilience concerning Indian imports appears robust, given the company's extensive operations and established relationships with suppliers. The focus on finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, suggests a streamlined procurement process. While specific details about backup suppliers and formulation diversity are not publicly available, Eurofarma's significant market presence implies strategic planning to mitigate potential disruptions. Ensuring compliance with regulatory standards, such as those set by the World Health Organization (WHO), is essential for maintaining the integrity and reliability of the supply chain.

Importing Pharmaceuticals into Brazil — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Brazil

1Regulatory Authority & Framework

In Brazil, the primary regulatory authority overseeing pharmaceutical imports is the Agência Nacional de Vigilância Sanitária (ANVISA). ANVISA is responsible for ensuring that imported pharmaceutical products meet the country's health and safety standards. Key legislation governing pharmaceutical imports includes Law No. 9,782/1999, which established ANVISA, and Law No. 6,360/1976, which regulates the sanitary surveillance of products and services. The marketing authorization pathway for Indian generics involves obtaining ANVISA approval, which requires compliance with specific regulatory requirements, including submission of detailed product dossiers and adherence to Good Manufacturing Practice (GMP) standards. (gov.br)

2Import Licensing & GMP

Import licensing in Brazil necessitates that foreign companies partner with a legally constituted entity within the country, which assumes responsibility for marketing authorization, importing, distribution, and post-marketing surveillance. For Indian exporters, obtaining GMP certification recognized by ANVISA is crucial. ANVISA accepts certifications from reputable organizations such as the European Medicines Agency (EMA), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, Indian exporters must secure wholesale distribution authorization to operate within Brazil's regulatory framework. (gov.br)

Eurofarma Laborat?rios S/A — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Eurofarma's focus on importing finished pharmaceutical formulations in the gastrointestinal and vitamins & supplements categories aligns with prevalent health concerns in Brazil, such as digestive disorders and nutritional deficiencies. The demand for these products is driven by an aging population, increasing awareness of health and wellness, and a growing middle class seeking accessible healthcare solutions. By concentrating on these therapeutic areas, Eurofarma addresses significant market needs, positioning itself as a key provider of essential health products.

2Sourcing Profile

Eurofarma's sourcing strategy emphasizes finished pharmaceutical formulations, particularly in the gastrointestinal and vitamins & supplements categories. This focus suggests a preference for ready-to-market products that can be swiftly integrated into the company's distribution network. India's established pharmaceutical manufacturing capabilities, recognized for quality and cost-effectiveness, make it a strategic partner for Eurofarma. This sourcing approach enables Eurofarma to offer a diverse range of products while maintaining stringent quality standards.

3Market Positioning

Seller's Guide — How to Become a Supplier to Eurofarma Laborat?rios S/A

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Eurofarma, particularly in the gastrointestinal and vitamins & supplements categories. Eurofarma's concentrated sourcing pattern indicates a strategic focus on specific high-demand products, suggesting potential gaps that new suppliers could fill. By aligning with Eurofarma's quality standards and regulatory requirements, Indian exporters can establish partnerships that leverage Eurofarma's extensive distribution network and market presence.

2Requirements & Qualifications

Indian exporters seeking to supply Eurofarma and the Brazilian market must obtain GMP certification recognized by ANVISA, such as those from the EMA, WHO, or PIC/S. They must also secure wholesale distribution authorization to operate within Brazil's regulatory framework. Compliance with ANVISA's quality standards, including batch testing, stability studies, and labeling requirements in Portuguese, is essential. Additionally, adherence to serialization mandates is necessary to ensure product traceability and prevent counterfeit products from entering the market. (gov.br)

3How to Approach

Frequently Asked Questions — Eurofarma Laborat?rios S/A

What products does Eurofarma Laborat?rios S/A import from India?

Eurofarma Laborat?rios S/A imports 2 pharmaceutical products across 2 categories. Top imports: Esomeprazole ($3.0M), Magnesium ($3.0M).

What is Eurofarma Laborat?rios S/A's total pharmaceutical import value?

Eurofarma Laborat?rios S/A's total pharmaceutical import value from India is $6.1M, based on 122 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Eurofarma Laborat?rios S/A focus on?

Eurofarma Laborat?rios S/A imports across 2 categories. The largest: Gastrointestinal (50.0%), Vitamins & Supplements (50.0%).

Get Full Eurofarma Laborat?rios S/A Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Eurofarma Laborat?rios S/A

Eurofarma Laborat?rios S/A — Import Portfolio & Supplier Network

What Products Does Eurofarma Laborat?rios S/A Import?

Top Products by Import Value

Eurofarma Laborat?rios S/A Therapeutic Categories — 2 Specializations